Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
106M
-
Number of holders
-
186
-
Total 13F shares, excl. options
-
84.1M
-
Shares change
-
-558K
-
Total reported value, excl. options
-
$1.19B
-
Value change
-
+$2.45M
-
Put/Call ratio
-
1.06
-
Number of buys
-
93
-
Number of sells
-
-78
-
Price
-
$14.13
Significant Holders of CORCEPT THERAPEUTICS INC - Common Stock (CORT) as of Q3 2019
217 filings reported holding CORT - CORCEPT THERAPEUTICS INC - Common Stock as of Q3 2019.
CORCEPT THERAPEUTICS INC - Common Stock (CORT) has 186 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 84.1M shares
of 106M outstanding shares and own 79.4% of the company stock.
Largest 10 shareholders include BlackRock Inc. (15.5M shares), VANGUARD GROUP INC (10.9M shares), FEDERATED INVESTORS INC /PA/ (9.24M shares), INGALLS & SNYDER LLC (8.71M shares), RENAISSANCE TECHNOLOGIES LLC (6.52M shares), STATE STREET CORP (2.92M shares), DIMENSIONAL FUND ADVISORS LP (2.55M shares), GEODE CAPITAL MANAGEMENT, LLC (1.42M shares), Invesco Ltd. (1.42M shares), and NORTHERN TRUST CORP (1.3M shares).
This table shows the top 186 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.